pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease
Status: COMPLETED
Conditions: Alzheimer Disease|Cognitive Impairment, Mild|Dementia, Mild
Interventions: BEHAVIORAL: Smartphone Personal Assistant|BEHAVIORAL: Implementation Intention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: The Effect of Mindfulness-based Cognitive Behavior Therapy on Occupational Stress Management
Status: COMPLETED
Conditions: Occupational Stress
Interventions: BEHAVIORAL: Cognitive behavior therapy (CBT) and Mindfulness-based stress reduction (MBSR) programs
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
Status: RECRUITING
Conditions: Cerebral Palsy Spastic Diplegia
Interventions: DRUG: OnabotulinumtoxinA|OTHER: Conventional Physical Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study
Status: RECRUITING
Conditions: Anxiety Disorder of Childhood|Fear|Shyness
Interventions: BEHAVIORAL: Being Brave|OTHER: Parent Education
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Analysis of Biliodigestive Anastomosis Techniques (BDA)
Status: COMPLETED
Conditions: Continuous or Interrupted Suture
Interventions: PROCEDURE: Continuous suture technique|PROCEDURE: Interrupted suture technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: CYP cocktail|DRUG: Fexofenadine 30mg|DIETARY_SUPPLEMENT: Red ginseng|DIETARY_SUPPLEMENT: Fermented-red ginseng
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Clinical trial: CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity
Status: COMPLETED
Conditions: Obesity|Laparoscopic Gastric Bypass Surgery|Surgical Conditions|Respiratory Function|Cerebral Tissue Oxygenation
Interventions: DRUG: deep neuromuscular blockade with rocuronium, reversal with sugammadex|DRUG: normal neuromuscular blockade reversal with rocuronium, reversal with neostigmine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Intravenous diclofenac sodium (DIC075V)|DRUG: Intravenous diclofenac sodium (DIC075V)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality
Status: WITHDRAWN
Conditions: Restoration of Function to CVADs
Interventions: DRUG: CUSA-081
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteers
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: BVL-GSK098 capsule, placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer
Status: UNKNOWN
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab QW, Trastuzumab Q3W
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.
Status: COMPLETED
Conditions: Influenza, Human
Interventions: BIOLOGICAL: Study group - quadrivalent recombinant hemagglutinin influenza vaccine|BIOLOGICAL: Control group - quadrivalent inactivated influenza vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer
Status: TERMINATED
Conditions: Gastric Cancer
Interventions: DRUG: Rilotumumab|DRUG: Placebo|DRUG: Cisplatin|DRUG: Capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Reducing Frailty for Older Cancer Survivors Using Supplements II
Status: RECRUITING
Conditions: Frailty|Inflammation
Interventions: DRUG: Epigallocatechin-3-Gallate (EGCG)|DRUG: Microcrystalline cellulose (MCC)|DIETARY_SUPPLEMENT: Ascorbic Acid (Vitamin C)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Protocols for Improved in Vitro Fertilization (IVF) Outcomes
Status: TERMINATED
Conditions: Infertility
Interventions: DRUG: Microflare protocol for IVF|DRUG: Antagonist protocol for IVF|DRUG: Demi-halt protocol for IVF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
Status: COMPLETED
Conditions: Schizophrenia|Prodrome
Interventions: DRUG: Omega 3 fatty acids
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin
Status: COMPLETED
Conditions: Hepatitis C
Interventions: BEHAVIORAL: Hep-Net Intervention|BEHAVIORAL: Usual Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
Status: RECRUITING
Conditions: Osteoarthritis|Osteo Arthritis Knee|Osteo Arthritis Shoulders|Osteoarthritis of Multiple Joints|Osteoarthritis, Hip|Osteoarthritis - Ankle/Foot
Interventions: PROCEDURE: Tissue Stromal Vascular Fraction (tSVF) Arm 1|BIOLOGICAL: PRP Concentrate Arm 1|PROCEDURE: Tissue Stromal Vascular Fraction (tSVF) Arm 2|BIOLOGICAL: PRP Concentrate Arm 2|PROCEDURE: Cellular Stromal Vascular Fraction (cSVF) Arm 2|PROCEDURE: Cellular Stromal Vascular Fraction (cSVF) Arm 3|DRUG: Sterile Normal Saline (IV Solution)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
Status: TERMINATED
Conditions: Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma
Interventions: OTHER: pharmacological study|DRUG: tacrolimus|DRUG: sirolimus|BIOLOGICAL: anti-thymocyte globulin|DRUG: fludarabine phosphate|DRUG: busulfan|DRUG: bortezomib|PROCEDURE: allogeneic hematopoietic stem cell transplantation|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Status: COMPLETED
Conditions: Influenza
Interventions: BIOLOGICAL: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: BIBW 2992 (Afatinib) in Head & Neck Cancer
Status: COMPLETED
Conditions: Head and Neck Neoplasms|Carcinoma, Squamous Cell
Interventions: DRUG: BIBW 2992|DRUG: Cetuximab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)
Status: COMPLETED
Conditions: Solid Tumor, Adult
Interventions: DRUG: INVAC-1 given in the previous phase 1 NCT02301754. No new injection is required in this study.
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Unified Protocol for Bariatric Surgery Candidates
Status: NOT_YET_RECRUITING
Conditions: Emotional Disorder|Anxiety|Depression
Interventions: BEHAVIORAL: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
Status: COMPLETED
Conditions: Basal Cell Carcinoma
Interventions: DRUG: PDT with Metvix 160 mg/g cream|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Status: COMPLETED
Conditions: Carcinoma of Unknown Primary|Lung Cancer
Interventions: BIOLOGICAL: filgrastim|DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: paclitaxel|DRUG: topotecan hydrochloride|PROCEDURE: peripheral blood stem cell transplantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Status: COMPLETED
Conditions: Carcinoma, Squamous Cell|Head and Neck Neoplasms|Oropharyngeal Neoplasms
Interventions: RADIATION: Intensity Modulated Radiotherapy (IMRT)|DRUG: Cisplatin (or alternative)|PROCEDURE: Assessment for surgical evaluation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers
Status: COMPLETED
Conditions: Healthy|Drug Interaction
Interventions: DRUG: PF-04991532 alone|DRUG: PF-04991532 + cyclosporine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
Status: TERMINATED
Conditions: Crohn Disease
Interventions: PROCEDURE: Mesenteric Sparing Ileocolic Resection|PROCEDURE: High Ligation Ileocolic Resection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
Status: COMPLETED
Conditions: Hot Flashes|Menopause|Vasomotor Symptoms
Interventions: DRUG: Escitalopram|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Pancreatic Adenocarcinoma
Interventions: DRUG: Y101D
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness
Status: NOT_YET_RECRUITING
Conditions: COVID-19
Interventions: DRUG: Nitazoxanide|DIETARY_SUPPLEMENT: Vitamin Super-B Complex|DRUG: Placebo|OTHER: Standard of Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Early Signs of Atherosclerosis in Obstructive Sleep Apnea: Effects of Treatment
Status: COMPLETED
Conditions: Obstructive Sleep Apnea|Atherosclerosis
Interventions: DEVICE: Continuous positive airway pressure (CPAP)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT
Clinical trial: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Status: TERMINATED
Conditions: Acral Lentiginous Melanoma|Mucosal Melanoma
Interventions: DRUG: Nivolumab|DRUG: Ipilimumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Role of Topical Tranexamic Acid in Total Hip Arthroplasty
Status: TERMINATED
Conditions: Post Operative Blood Loss
Interventions: DRUG: Tranexamic Acid|DRUG: Normal Saline Solution
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Non-pharmacological Pain Management in Term Neonates
Status: COMPLETED
Conditions: Pain
Interventions: OTHER: White Noise|OTHER: Facilitated Tucking|OTHER: White Noise+Facilitated Tucking
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Status: RECRUITING
Conditions: Type 1 Hyperlipoprotenemia
Interventions: DRUG: Orlistat|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2
Status: UNKNOWN
Conditions: Lung Adenocarcinoma Patients With Postoperative in pN2
Interventions: RADIATION: intensity-modulated radiation|RADIATION: intensity-modulated radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparative Study Between Shear and Strain Elastography in Monitoring the Response to NAC in Breast Cancer Patients
Status: NOT_YET_RECRUITING
Conditions: Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy Using SE and SWE
Interventions: DEVICE: shear wave and strain elastography
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease
Status: TERMINATED
Conditions: Sickle Cell-hemoglobin SS Disease|Vaso-occlusive Crisis
Interventions: DEVICE: Non invasive positive pressure ventilation|DEVICE: Spirometry
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: The mCME Project:Delivering Continuing Medical Education for Community Health Workers Via SMS Text Messages
Status: COMPLETED
Conditions: Medical Knowledge
Interventions: BEHAVIORAL: Group 2 intervention daily SMS bullet point|BEHAVIORAL: Group 3 intervention daily SMS bullet point
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis
Status: COMPLETED
Conditions: Knee Osteoarthritis|Knee Pain Chronic|Joint Disease|Arthritis|Osteo Arthritis Knee|Musculoskeletal Disease
Interventions: PROCEDURE: HAM and HUMCWJ Injections
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients
Status: UNKNOWN
Conditions: Carcinoma, Hepatocellular
Interventions: DEVICE: TACE|DRUG: Anlotinib Hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
Status: UNKNOWN
Conditions: Advanced HR+ HER2 Negative Breast Carcinoma
Interventions: DRUG: (CDK)4/6 inhibitor
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery
Status: UNKNOWN
Conditions: Endoscopic Sinus Surgery|Fentanyl
Interventions: DRUG: Saline 0.9%|DRUG: Levobupivacaine Hydrochloride|DRUG: Fentanyl|DRUG: Dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
Status: UNKNOWN
Conditions: Sudden Loss of Hearing
Interventions: PROCEDURE: bed rest|DRUG: prednisone - oral corticosteroid 1mg/kg/D for 1 week
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA
Status: COMPLETED
Conditions: HIV-infection/Aids|Malnutrition
Interventions: DIETARY_SUPPLEMENT: Ready-to-use therapeutic food (RUTF)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Response of Cardiovascular Parameters to Physical Therapy Post Liver Transplantation
Status: COMPLETED
Conditions: Liver Transplant; Complications
Interventions: PROCEDURE: 6 minute walk test , Blood pressure monitoring
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
Status: RECRUITING
Conditions: Heart Failure|Iron Deficiency
Interventions: DRUG: High-dose ferric derisomaltose|DRUG: Low-dose ferric derisomaltose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery
Status: UNKNOWN
Conditions: Nitric Oxide|Hypoxemia|Aortic Surgery
Interventions: DRUG: Inhaled Nitric Oxide|DEVICE: lung protective mechanical ventilation|DEVICE: Hemodynamic monitoring
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Aspiration of Residual Gastric Contents
Status: COMPLETED
Conditions: Infant, Premature|Nutrition, Enteral
Interventions: PROCEDURE: No aspiration of gastric contents|PROCEDURE: Routine aspiration of gastric contents
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Treatment of Anxiety and Anorexia Nervosa in Adolescents
Status: COMPLETED
Conditions: Anxiety|Anorexia Nervosa
Interventions: DRUG: Fish oil|DRUG: Placebo pill
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers
Status: COMPLETED
Conditions: Alzheimer's Disease
Interventions: DRUG: florbetapir F 18
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component
Status: COMPLETED
Conditions: Osteoarthritis|Arthritis|Avascular Necrosis|Fracture of the Femoral Neck or Head|Congenital Hip Dysplasia
Interventions: PROCEDURE: Anterior Minimally Invasive Approach (AMIS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Status: COMPLETED
Conditions: Hepatocellular Carcinoma
Interventions: OTHER: TACE|OTHER: TACE+ RTC
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
Status: COMPLETED
Conditions: Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer
Interventions: DRUG: cediranib maleate|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.
Status: UNKNOWN
Conditions: Idiopathic Pulmonary Fibrosis
Interventions: OTHER: Supportive care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Status: COMPLETED
Conditions: Adrenal Tumors|Adrenal Malignancies|Abnormal Hormonal Secretions|Electrolytes Abnormalities
Interventions: PROCEDURE: Imaging, Adrenal acans|RADIATION: (NP-59)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Innate Immunity in Ozone-induced Airway Inflammation in COPD
Status: ACTIVE_NOT_RECRUITING
Conditions: Pulmonary Disease, Chronic Obstructive|Airway Disease|COPD Exacerbation|Pollution; Exposure|Pollution Related Respiratory Disorder
Interventions: OTHER: Ozone exposure
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status
Status: COMPLETED
Conditions: Glioblastoma
Interventions: DRUG: Cilengitide (2-times weekly)|DRUG: cilengitide (5-times weekly)|DRUG: Temozolomide|RADIATION: Radiotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
Status: RECRUITING
Conditions: Anterior Cruciate Ligament Injuries
Interventions: DEVICE: Non-invasive Neuromodulation|DEVICE: Placebo Non-invasive Neuromodulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management
Status: COMPLETED
Conditions: Type 2 Diabetes Treated With Insulin
Interventions: OTHER: INS-MOBILE: Mobile Application Developed for Insulin Use
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Status: RECRUITING
Conditions: Primary Ciliary Dyskinesia|Primary Immune Deficiency|Kartagener Syndrome
Interventions: DIAGNOSTIC_TEST: Genetic Testing for PCD or PID|OTHER: Unaffected Family Member Genetic Testing
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Status: RECRUITING
Conditions: Gastrointestinal Cancer|Hematologic Cancer|Thoracic Cancer
Interventions: BEHAVIORAL: SURGE
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer (Part I Study)
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DEVICE: Diagnostic microprobe (inPROBE) medical device
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Target Temperature Management In Myocardial Infarction - A Pilot Study
Status: COMPLETED
Conditions: ST-elevation Myocardial Infarction
Interventions: DEVICE: EMCOOLS flex pad; Philips Innercool RTx
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)
Status: COMPLETED
Conditions: Ankylosing Spondylitis
Interventions: DRUG: Etoricoxib|DRUG: Other Cox-2 inhibitors|DRUG: Other Non-selective NSAIDs|OTHER: No anti-inflammatory treatment
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)
Status: COMPLETED
Conditions: Chronic Total Occlusion of Coronary Artery|Optical Coherence Tomography|Ischemic Cardiomyopathy|Neointimal Hyperplasia|Stent Thrombosis
Interventions: PROCEDURE: Percutaneous recanalization of chronic total occlusion
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: COMPLETED
Conditions: Primary Immune Deficiency Disorders|Common Variable Immunodeficiency|X-linked Agammaglobulinaemia|Hyper-IgM Syndrome
Interventions: BIOLOGICAL: Gammaplex (5%)|BIOLOGICAL: Gammaplex 10
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance
Status: TERMINATED
Conditions: Heart Block|Sick Sinus Syndrome|Atrioventricular Block|Ventricular Dysfunction
Interventions: OTHER: Cardiac MRI with pacemaker stimulation|OTHER: Cardiac MRI with and without pacemaker stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
Status: COMPLETED
Conditions: Acne Vulgaris
Interventions: DRUG: Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75%|DRUG: Onexton™ Gel|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Pain Control in Diagnostic Hysteroscopy
Status: COMPLETED
Conditions: Pain, Postoperative
Interventions: COMBINATION_PRODUCT: Ibuprofen-Paracetamol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy
Status: COMPLETED
Conditions: Posterior Fossa Tumor
Interventions: DRUG: ultrasound guided Greater occipital nerve block|DRUG: control group C
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects
Status: UNKNOWN
Conditions: Healthy Adult Subjects
Interventions: DRUG: CuminUP30|DRUG: Curcumin capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic
Status: COMPLETED
Conditions: Diabetic Foot Ulcer
Interventions: DEVICE: SECONDARY dressing gauze and tape|PROCEDURE: debridement, irrigation|DEVICE: Dermagraft|DEVICE: Oasis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Status: COMPLETED
Conditions: Ankylosing Spondylitis
Interventions: DRUG: Bimekizumab|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Natural Language Processing and Quality Assessment in Primary Care
Status: COMPLETED
Conditions: Diabetes
Interventions: OTHER: Brochure: Care of the Feet for Those at Risk|OTHER: Quality Survey: foot exam, tobacco and aspirin use
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
Status: COMPLETED
Conditions: Type 1 Diabetes|Peripheral Neuropathy
Interventions: DRUG: Salsalate|DRUG: PLACEBO
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training
Status: RECRUITING
Conditions: Fibromyalgia, Primary|Chronic Pain|Exercise Addiction
Interventions: OTHER: exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
Status: COMPLETED
Conditions: ST Elevation Myocardial Infarction
Interventions: DRUG: ATH3G10|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens
Status: COMPLETED
Conditions: Myopia
Interventions: DEVICE: galyfilcon A prototype lens|DEVICE: lotrafilcon B lens
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease
Status: COMPLETED
Conditions: Sacrococcygeal Fistula|Pilonidal Sinus|Pilonidal Disease|Pilonidal Disease of Natal Cleft
Interventions: DRUG: phenolization|PROCEDURE: Conventional surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Risk-Reducing Surgeries for Hereditary Ovarian Cancer
Status: UNKNOWN
Conditions: Hereditary Breast and Ovarian Cancer Syndrome|Colorectal Neoplasms, Hereditary Nonpolyposis|Ovariectomy|Hysterectomy
Interventions: PROCEDURE: salpingo-oophorectomy only by laparoscopy|PROCEDURE: salpingo-oophorectomy with hysterectomy by laparoscopy|OTHER: Follow-up
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies
Status: UNKNOWN
Conditions: B Cell Lymphoma|B Cell Leukemia
Interventions: BIOLOGICAL: CD19 CARvac T cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Two Types of Pain Relief After Cesarean Delivery
Status: TERMINATED
Conditions: Cesarean Section
Interventions: OTHER: Transversus Abdominis Plane (TAP) Block|OTHER: Incisional Infiltration of Local Anesthetic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Verticalization Robotic Exoskeleton DoC
Status: UNKNOWN
Conditions: Brain Injuries|Disorder of Consciousness
Interventions: OTHER: Robotic Mobility Device (REX)|OTHER: Tilt Table
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
Status: UNKNOWN
Conditions: Ectopic Pregnancy
Interventions: DRUG: Methotrexate|DRUG: Letrozole|DRUG: cetrotide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Radius Loading in Primary Hyperparathyroidism
Status: COMPLETED
Conditions: Primary Hyperparathyroidism|Bone Diseases, Metabolic|Osteoporosis, Postmenopausal|Bone Loss, Postmenopausal
Interventions: OTHER: Forearm exercise program|OTHER: Walking program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections
Status: ACTIVE_NOT_RECRUITING
Conditions: Augmentation|Reconstruction
Interventions: BIOLOGICAL: Scaffold and adipose-derived stromal cell enriched fat grafts
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of Sleep Quality and Mental Health After Using Meditation
Status: ACTIVE_NOT_RECRUITING
Conditions: Insomnia|Insomnia Chronic|Insomnia Disorder|Sleep Disorder|Anxiety Disorders|Stress Disorder|Depressive Disorder|Quality of Life|Complementary Therapy|Spirituality
Interventions: OTHER: Shabad Kriya Meditation|OTHER: Relaxing reading
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer
Interventions: OTHER: high performance liquid chromatography|OTHER: laboratory biomarker analysis|OTHER: mass spectrometry|OTHER: medical chart review
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: COMPLETED
Conditions: Crohn's Disease
Interventions: DRUG: GSK1605786 500 mg|DRUG: Midazolam 3 mg|DRUG: Pioglitazone 15 mg|DRUG: Omeprazole 40 mg|DRUG: Rosuvastatin 10 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Engineering an Online STI Prevention Program: CSE2
Status: COMPLETED
Conditions: Alcohol Consumption|Sexually Transmitted Diseases
Interventions: BEHAVIORAL: Knowledge Alone|BEHAVIORAL: Self-efficacy alone|BEHAVIORAL: Perceived benefits alone|BEHAVIORAL: Benefits and self-efficacy|BEHAVIORAL: Injunctive norms alone|BEHAVIORAL: Injunctive norms and self-efficacy|BEHAVIORAL: Injunctive norms and benefits|BEHAVIORAL: Injunctive norms, benefits, self-efficacy|BEHAVIORAL: Descriptive norms alone|BEHAVIORAL: Descriptive norms and self-efficacy|BEHAVIORAL: Descriptive norms and perceived benefits|BEHAVIORAL: Descriptive norms, benefits, self-efficacy|BEHAVIORAL: Descriptive norms and injunctive norms|BEHAVIORAL: Descriptive and injunctive norms, self-efficacy|BEHAVIORAL: Descriptive and injunctive norms, and benefits|BEHAVIORAL: Descriptive & injunctive norms, benefits, efficacy|BEHAVIORAL: Expectancies alone|BEHAVIORAL: Expectancies and self-efficacy|BEHAVIORAL: Expectancies and perceived benefits|BEHAVIORAL: Expectancies, benefits, self-efficacy|BEHAVIORAL: Expectancies and injunctive norms|BEHAVIORAL: Expectancies, injunctive norms, self-efficacy|BEHAVIORAL: Expectancies, injunctive norms, and benefits|BEHAVIORAL: Expectancies, injunctive norms, benefits, efficacy|BEHAVIORAL: Expectancies and descriptive norms|BEHAVIORAL: Expectancies, descriptive norms, & self-efficacy|BEHAVIORAL: Expectancies, descriptive norms, benefits|BEHAVIORAL: Expectancies, descriptive norms, benefits, efficacy|BEHAVIORAL: Expectancies, descriptive and injunctive norms|BEHAVIORAL: Expectancies, descriptive & injunctive norms, efficacy|BEHAVIORAL: Expectancies, descriptive & injunctive norms, benefits|BEHAVIORAL: Expectancies, descriptive & injunctive, benefits, efficacy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Safety of Anticoagulant Therapy After Endoscopic Treatment
Status: COMPLETED
Conditions: Cirrhosis|Portal Vein Thrombosis|Esophageal and Gastric Varices|Anticoagulant-induced Bleeding
Interventions: DRUG: nadroparin calcium-warfarin sequential anticoagulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: Placebo|DRUG: GSK2330811
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Status: COMPLETED
Conditions: Endothelial Dysfunction
Interventions: OTHER: Nicotine Replacement Therapy (NRT)|DIETARY_SUPPLEMENT: Gamma-Tocopherol|OTHER: Placebo|BEHAVIORAL: Smoking cessation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
Status: RECRUITING
Conditions: Relapsed Peripheral T-Cell Lymphoma|Refractory Peripheral T-Cell Lymphoma
Interventions: DRUG: Pembrolizumab IV infusion Q3W, with daily oral Olaparib.
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145
Status: COMPLETED
Conditions: Ovarian Cancer
Interventions: DRUG: KAND145|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
Status: COMPLETED
Conditions: Esophageal Adenocarcinoma|Esophagus SCC|Cholangiocarcinoma|Urothelial/Bladder Cancer, Nos|Endometrial Cancer
Interventions: DRUG: Abemaciclib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
Status: UNKNOWN
Conditions: Bronchiectasis
Interventions: DRUG: Cholecalciferol|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Molecular Effects of Topical Calcipotriene on Morphea
Status: TERMINATED
Conditions: Morphea|Localized Scleroderma
Interventions: DRUG: topical calcipotriene 0.005% ointment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
Status: COMPLETED
Conditions: Injuries, Spinal Cord|Neurogenic Bowel|Urinary Bladder, Neurogenic
Interventions: BEHAVIORAL: Health Mechanics Program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck
Status: ACTIVE_NOT_RECRUITING
Conditions: Squamous Cell Carcinoma of Head and Neck
Interventions: DRUG: Atezolizumab|DRUG: Tiragolumab|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis
Status: ACTIVE_NOT_RECRUITING
Conditions: Endometriosis Associated Pelvic Pain
Interventions: DRUG: Dienogest (BAY86-5258, Visanne)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)
Status: COMPLETED
Conditions: COVID-19
Interventions: DRUG: Ivermectin Oral Product|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base
Status: COMPLETED
Conditions: Dental Plaque
Interventions: DRUG: Chlorhexidine|DRUG: Chlorhexidine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab
Status: RECRUITING
Conditions: Pediatric ALL|Child, Hospitalized|Physical Therapy Modalities|Occupational Therapy|Animal Assisted Therapy
Interventions: DEVICE: Paro Robot
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
Status: COMPLETED
Conditions: Obesity|Overweight
Interventions: DRUG: Tirzepatide|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Acetaminophen (APAP) +/- Oxycodone
Status: COMPLETED
Conditions: Musculoskeletal Pain
Interventions: DRUG: Acetaminophen|DRUG: Oxycodone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: ASCENT Intervention for Brain Tumor Patients
Status: NOT_YET_RECRUITING
Conditions: Malignant Brain Tumor|Glioma|Coping Skills|Distress, Emotional
Interventions: BEHAVIORAL: Psychosocial intervention|OTHER: Usual supportive care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effect of Combined Use of an Allograft and Membrane on the Healing Outcome of Apicomarginal Defects
Status: UNKNOWN
Conditions: Apicomarginal Defects
Interventions: PROCEDURE: Periapical surgery with placement of an allograft and a membrane
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Status: COMPLETED
Conditions: HIV Infections
Interventions: DRUG: Indinavir sulfate|DRUG: Zidovudine
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn
Status: COMPLETED
Conditions: Burns
Interventions: DRUG: Recombinant Factor VIIa|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT